Dr. Schreiber joined EXUMA Biotech as the Senior Director of IP Strategy & Licensing in April 2016. He brings more than 14 years of experience in intellectual property protection and patent portfolio development through licensing. Previously, Dr. Schreiber led the Office of Academic Alliances and Technology Licensing at Intrexon Corporation. From 2006-2015, he was a member of the corporate development and legal teams at Invitrogen, Life Technologies and Thermo Fisher Scientific, where he was responsible for in-licensing technologies that formed the basis of more than a dozen commercial product lines for cell and molecular biology research. Prior to entering industry, he was an Associate Director in the technology licensing office at The Johns Hopkins University. Dr. Schreiber is registered to practice before the U.S. Patent and Trademark Office and is a Certified Licensing Professional. He received his B.A. in biochemistry from the University of California, Berkeley and his Ph.D. in immunology from Washington University.
Greg Schreiber, Ph.D.Senior Director, IP & Licensing